AngioDynamics

Congratulations to Dr. Butty and team at Indiana University Health for their first AlphaVac F1885 system procedure for #PulmonaryEmbolism. Thank you to Dr. Butty and team for their partnership in patient care. The AlphaVac F1885 system is now indicated for the treatment of pulmonary embolism. To learn more visit Alpha-Vac.com #MedTechInnovator #Pulmonary#Embolism Risk Info: https://lnkd.in/gFNG_pA

🏆 Highlighting Excellence 🏆 This was an exciting year for the members of our Restorative Flow Therapies - Venous team. We are grateful to be able to celebrate milestones hit this past year, but this was an important week to learn, educate, train, and prepare for what's next for this special team. Everyone worked so hard all week which made taking the time to celebrate our #PresidentsClub Winners even more special. Congrats to those who won and thank you to the team for a great year. #AlphaVac #AngioVac #SalesExcellence #LevelUp Aubree Paulus Brooks Knapek, MBA Tyler Koors Tom Weinkam Matthew Gielow Rob Modzelewski David Turnbull

🌟 Highlights from This Year's Global Sales Meeting! 🌟 Our teams participated in advanced training sessions and educational workshops, sharpening their skills and expanding their knowledge. The energy was palpable, with everyone committed to learning, growing, and #LevelingUp to push the boundaries of excellence. A highlight of the event was celebrating our President's Club winners. These outstanding individuals have demonstrated unparalleled dedication, exceptional performance, and a relentless pursuit of excellence. It was an honor to recognize their achievements and celebrate their contributions to our shared mission of supporting caregivers and improving patients' lives. Swipe through the images to see some of our President's Club winners and join us in congratulating them on their phenomenal accomplishments! 🏆✨ Mitch Vanderpoll Leon N. Nicolas Buffaud Bill Kline Jolean Tsang Kasey Newcomb #GlobalSalesMeeting #PresidentsClub #SalesExcellence #TeamAchievement #CelebratingSuccess #ContinuousLearning

We're excited to share moments from our recent Global Sales Meeting, where our commercial teams came together for an incredible mix of training, education, and celebration. This year's event was exceptional, and we couldn't be prouder of the high achievers who continue to drive our success. We would like to honor the following President’s Club Winners from our Interventional Devices team, including TWO A.C.E Award Winners: David Bamiro Eric Biernbaum Kirsten Cleveland Cory Connolly Jeff Thompson Congratulations to the entire Interventional Devices team on a great year and here's to #LevellingUp for FY25! #MedicalDevice #GlobalSalesMeeting #PresidentsClub #SalesExcellence #TeamAchievement #CelebratingSuccess #ContinuousLearning

Congratulations to William Harris and team at Parkridge Medical Center for their latest AlphaVac F1885 system procedure for #PulmonaryEmbolism. Thank you to Dr. Harris and team for their partnership in patient care. We are excited to hear that the patient is doing great! The AlphaVac F1885 system is now indicated for the treatment of pulmonary embolism. To learn more visit Alpha-Vac.com #MedTechInnovator #Pulmonary#Embolism Risk Info: https://lnkd.in/gFNG_pA

Last week, the AngioDynamics team gathered in Orlando, Florida, to celebrate our collective and individual successes in FY24 and to kick off FY25. We had an incredible year, and it was wonderful to acknowledge the hard work and dedication that brought us here. A special congratulations to the President’s Club winners for FY24 and to those who earned promotions. Here's to another fantastic year ahead! Chad T. Campbell Chad Reed Tim Helfrich Chris Orlaska Mark Manning Melissa Guiry

We will be at Society for Cardiovascular Angiography & Interventions next week to discuss the #AlphaVac F1885 system and its new indication for the treatment of #PulmonaryEmbolism! Stay tuned to learn more about our exciting updates at SCAI and visit booth 823 to see how the AlphaVac F1885 system can provide procedural efficiency while maintaining clinical safety and efficacy.  #SCAI2024 Learn more about the new indication here: https://lnkd.in/eTkx9j3v For additional product information visit Alpha-Vac.com For important risk information visit https://lnkd.in/gFNG_pA

Busy first day at #CVAA2024. Engaging discussions with our customers on our products and technology! #BioFo #SpectrumVascular

We want to take a moment to extend our deepest gratitude to each and every one of you for your incredible support during Blood Clot Awareness Month (BCAM) this past March. Together, we embarked on a mission to raise awareness and funds in remembrance of the 100,000 lives lost to blood clots annually. Our goal was ambitious: to raise $100,000 and reach 100,000 people with life-saving information about blood clots. Thanks to your dedication and generous support, along with the generous support of our corporate partners and sponsors, we are thrilled to announce that we’ve exceeded our expectations. Together we raised an astounding $174,500, far surpassing our initial goal. Additionally, we’ve reached a record-breaking 4.8 million people with crucial information about blood clots. This is a testament to the power of community and collective action. Thank you to everyone who contributed to this remarkable success. Whether you shared life-saving blood clot information, wrote to Congress, participated in our 100,000 Reasons Challenge, shared a loved one’s story, raised funds, donated, or volunteered your time, your efforts have made a significant impact. Also, join us in celebrating the top three individuals and teams who crushed our 100,000 Reasons Challenge! AngioDynamics Penumbra, Inc. #stoptheclot #bcam #bcam2024 #bloodclotawarenessmonth #bloodclotawareness #bloodclotprevention #bloodclotsurvivor #bloodclotpatient

We are excited to announce that the #AlphaVac F1885 System has received 510(k) clearance for an expanded indication that includes the treatment of #PulmonaryEmbolism. We would like to thank all our patient care partners who have helped to provide people affected by PE with a safe and effective treatment option. The AlphaVac F1885 system is designed to optimize navigation within the pulmonary arteries to efficiently remove pulmonary emboli. We are proud of the work that has gone into providing healthcare professionals with an advanced tool to efficiently address a wider range of patient needs. Learn more about the new indication here: https://lnkd.in/eTkx9j3v For additional product information visit Alpha-Vac.com For important risk information visit https://lnkd.in/gFNG_pA